Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Medivation
Medivation
A frustrated Sanofi makes $9.3 billion bid for Medivation and its cancer drug
Stat
Thu, 04/28/16 - 09:39 am
Sanofi
Medivation
M&A
Xtandi
4 Biotech Stocks You Should Be Watching Right Now
TheStreet.com
Fri, 04/22/16 - 09:08 pm
Five Prime
Inovio
Medivation
Ocular Therapeutix
Is Sanofi Trying to Acquire Medivation?
Yahoo/Market Realist
Thu, 04/21/16 - 09:02 am
Sanofi
Medivation
M&A
Medivation: It’s Not Just M&A
Barron's
Mon, 04/18/16 - 10:15 am
Medivation
M&A
AstraZenca
Sanofi
Gilead Sciences
talazoparib
PARP inhibitors
Report: AstraZeneca considering bid for cancer biotech Medivation
BioPharma Dive
Mon, 04/18/16 - 09:44 am
AstraZeneca
Medivation
Sanofi
M&A
Xtandi
3 Biotech Takeover Targets That Could Get Bought Soon
Motley Fool
Wed, 04/13/16 - 10:32 pm
biotech
M&A
Kite Pharma
Portola Pharmaceuticals
Medivation
Medivation Said to Have Rebuffed Sanofi Takeover Approach
Bloomberg
Wed, 04/13/16 - 10:30 pm
Medivation
Sanofi
M&A
Medivation: Biotech’s Most Wanted?
Barron's
Wed, 04/13/16 - 09:53 am
Medivation
M&A
Amgen
Gilead Sciences
Sanofi
AstraZeneca
Why Gilead Sciences and Amgen Can Eye Medivation As Acquisition Target
Bidness, ETC
Tue, 04/5/16 - 08:48 am
Gilead Sciences
Amgen
Medivation
M&A
Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill
Motley Fool
Mon, 04/4/16 - 07:59 am
patents
hepatitis C
Medivation
Xtandi
Merck
Ionis Pharmaceuticals
Gilead Sciences
Medivation working with JPMorgan on takeover approaches -sources
Yahoo/Reuters
Wed, 03/30/16 - 09:27 pm
Medivation
JPMorgan
M&A
8 Biotech Stocks That Have a ‘Greater Probability’ of Being Acquired
Barron's
Tue, 03/29/16 - 12:24 pm
biotech
M&A
Ardelyx
Ophthotech
Medivation
Puma Biotechnology
Ultragenyx
Portola Pharmaceuticals
Versartis
Relypsa
Congress just fired a shot against its next drug-pricing target, and its shares took a hit
Yahoo/Business Insider
Mon, 03/28/16 - 09:10 pm
US Congress
drug pricing
Medivation
Astellas
Xtandi
Medivation Initiates Phase 2 Trial of MDV9300: Stock Rises 5.7%
Yahoo/Market Realist
Sat, 12/26/15 - 08:46 pm
Medivation
MDV9300
clinical trials
diffuse large B-cell lymphoma
Medivation's Xtandi sales force due for hiring, revamp as urology push falls flat
Fierce Pharma Marketing
Wed, 11/11/15 - 09:10 pm
Medivation
Xtandi
hirings
Astellas
4 Blockbuster Drugs Whose Sales Could Easily Double
Motley Fool
Mon, 10/26/15 - 08:46 am
Xtandi
Medivation
Astellas
Eliquis
Pfizer
Bristol-Myers Squibb
Revlimid
Celgene
Invokana
JNJ
3 Cancer Companies to Watch Closely in 2016
Motley Fool
Tue, 10/20/15 - 10:00 am
cancer
Celldex
Medivation
Clovis Oncology
rociletinib
talazoparib
Rintega
J&J's Earnings May Be Good News for Bristol-Myers Squibb and Medivation
Motley Fool
Mon, 10/19/15 - 09:39 am
JNJ
earnings
Bristol-Myers Squibb
Medivation
Medivation Destined To Become A Biotech Behemoth As Low-Risk Pipeline Expands
Seeking Alpha
Wed, 09/2/15 - 12:43 pm
talazoparib
Medivation
Xtandi
pidilizumab
Why BioMarin hawked a phase III cancer drug to Medivation for $570M
BioPharma Dive
Wed, 08/26/15 - 08:47 am
Biomarin
Medivation
BMN 673
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »